Ketesse

Dexketoprofen, the active ingredient in Ketesse, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an injectable solution for intramuscular and intravenous use. It is indicated for the relief of mild to moderate pain, post‑operative discomfort, musculoskeletal pain and other inflammatory conditions in adult patients. GNH USA supplies Ketesse as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Dexketoprofen acts as an NSAID to manage pain and inflammation across several clinical settings.

- Mild to moderate pain: provides rapid analgesia for acute pain episodes. - Post‑operative pain: reduces discomfort following surgical procedures. - Musculoskeletal pain: alleviates pain associated with strains, sprains and overuse injuries. - Inflammatory conditions: helps control inflammation in conditions such as bursitis or tendinitis.

Adverse reactions may occur with any NSAID therapy and should be monitored.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Injection site reactions: erythema, swelling or pain. - Elevated blood pressure. - Transient renal function changes.

Serious or Rare Side Effects: - Severe gastrointestinal bleeding or ulceration. - Anaphylactic or severe hypersensitivity reactions. - Hepatotoxicity: marked elevation of liver enzymes. - Renal failure or acute kidney injury. - Cardiovascular events: myocardial infarction or stroke. - Hematologic abnormalities: thrombocytopenia or leukopenia.

Before initiating therapy, consider patient‑specific risk factors and monitor appropriately.

- Renal impairment: assess kidney function and adjust use accordingly. - Hepatic disease: evaluate liver enzymes before treatment. - Cardiovascular risk: use cautiously in patients with hypertension or heart disease. - Gastrointestinal history: avoid in those with active ulcers or bleeding disorders. - Concomitant anticoagulants: monitor for increased bleeding risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Dexketoprofen may interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: increased gastrointestinal and renal toxicity. - High‑dose aspirin: additive antiplatelet effects.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: may exacerbate renal impairment. - Selective serotonin reuptake inhibitors (SSRIs): modest increase in bleeding risk. - Lithium: potential for increased lithium levels. - Methotrexate: reduced clearance leading to toxicity.